on M1 Kliniken AG (ETR:DE000A0S)
M1 Kliniken AG Reports Significant Financial Growth for 2025
Berlin-based M1 Kliniken AG has released its preliminary figures for the 2025 fiscal year, highlighting a substantial growth in EBIT by 29.2% and earnings per share increasing by 40%. Group revenue climbed by 7.4% to EUR 364.3 million, marking continued profitable growth.
The beauty segment exceeded expectations, crossing the EUR 100 million revenue threshold for the first time. This segment saw an 11.2% revenue rise to EUR 102 million, with an EBIT increase of 41.5%. The segment's success is attributed to optimized processes and targeted pricing strategies.
Moreover, M1 Kliniken AG successfully sold HAEMATO Pharm GmbH. This move aims to strengthen its position as a leading provider of medical aesthetics. Looking ahead, the company plans to expand its clinic network and further enhance its market presence internationally.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all M1 Kliniken AG news